Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

See allHide authors and affiliations

Science  24 Dec 2010:
Vol. 330, Issue 6012, pp. 1774
DOI: 10.1126/science.1197623

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed.  Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
Publication Date - String

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Enter the characters shown in the image.

Vertical Tabs

  • A Genetic Exploration of Alzheimer's Disease

    In their Brevia "Decreased clearance of CNS β-amyloid in Alzheimer's disease" (24 December 2010, p. 1774, published online 9 December 2010), K. G. Mawuenyega et al. present compelling evidence through use of stable isotope–labeling technology that clearance of soluble β-amyloid from the central nervous system (CNS) is reduced in Alzheimer's disease (AD). Further analysis of their data may also reveal important informat...

    Show More
    Competing Interests: None declared.